Akdital (AKT) Q3 2023 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2023 earnings summary
22 Oct, 2026Executive summary
Q3 2023 revenue rose 91% YoY; 9M revenue climbed 86%, supported by new facilities and growth at legacy Casablanca and El Jadida clinics.
Financial highlights
Revenue reached MAD 507M in Q3 2023 vs. MAD 265M in Q3 2022; 9M revenue was MAD 1,330M vs. MAD 716M.
Outlook and guidance
Expansion strategy targets a presence in 11 of Morocco’s 12 regions by 2025, with multiple clinic construction projects underway.
Expansion is intended to support Morocco’s rollout of mandatory health insurance.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Akdital
- Revenue rose 84% as expansion lifted net debt and the 2024 target to 34 facilities.AKT
H2 2023 - Revenue rose 61% as capacity expansion continued and net debt edged lower.AKTQ1 2024
- H1 revenue rose 51% as net income climbed 70%, with 51 hospitals targeted by 2026.AKTH1 2024
- H1 revenue grew 51% as clinic expansion lifted capacity to 2,698 beds.AKTQ2 2024
- Revenue grew 81% as capacity expanded; investment and net debt rose.AKTQ1 2023
- Revenue rose 54.9%, EBITDA grew 64.3%, and 12 facilities opened in 2024.AKTH2 2024
- Revenue rose 68% as three openings added 405 beds; net debt climbed 65%.AKTH1 2025
- Revenue rose 49% as expansion accelerated, while margins eased and net debt increased.AKTH2 2025
- Revenue rose 21% as the network expanded and Saudi hospital operations launched.AKTH1 2026